Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07348237 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)

StatusCompleted
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Lead sponsor: Merck Sharp & Dohme LLC to Merck Sharp & Dohme LLC Primary endpoints: details revised at 3 of 9 entries · Trial completed · Final enrollment: 18 participants (planned 24) · 4 more Show 7 more changesShow less
    • Primary endpoints: details revised at 3 of 9 entries
    • Trial completed
    • Final enrollment: 18 participants (planned 24)
    • Primary and study completion dates changed from estimate of Sep 21, 2026 to Sep 1, 2026
    • Eligibility criteria shortened, about 25 words
    • Secondary endpoints: details revised at 3 of 7 entries
    • Site details revised at 3 of 3 sites
  2. Primary and study completion pushed from Aug 18, 2026 to Sep 21, 2026v8
  3. Primary and study completion dates: Jul 20, 2026 to Aug 18, 2026v7
  4. Primary and study completion dates: Aug 18, 2026 to Jul 20, 2026v6
  5. Re-verified, no change to tracked fieldsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 1 to 3v4
  2. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date: Feb 24, 2026 to Mar 2, 2026v3 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date: Feb 24, 2026 to Mar 2, 2026
  3. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this trial is to measure what happens to 1 or 2 doses of MK-2828 in a person's body over time (pharmacokinetic or PK trial). Researchers want to learn if the PK of people with certain types of kidney disease is similar to the PK of healthy people.
Trial Details
NCT Number NCT07348237
Lead Sponsor Merck Sharp & Dohme LLC
Conditions Chronic Kidney Failure, End-Stage Renal Disease, Renal Impairment
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov